Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company is headquartered in Woburn, Massachusetts and currently employs 29 full-time employees. The company went IPO on 2006-11-10. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The firm is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).
Yield10 Bioscience Inc 주요 수익원은 Specialty Oils and Niche Crops이며, 최신 수익 발표에서 수익은 60,000입니다. 지역별로는 United States이 Yield10 Bioscience Inc의 주요 시장이며, 수익은 60,000입니다.
Yield10 Bioscience Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Yield10 Bioscience Inc의 순손실은 $-14입니다.